Siker Kimbung

Claudin‐2 is an independent negative prognostic factor in breast cancer and specifically predicts early liver recurrences

Siker Kimbung, Anikó Kovács, Pär‐Ola Bendahl et al. · Molecular Oncology · 2013 · 93 citations · Full text

RNA sequencing-based single sample predictors of molecular subtype and risk of recurrence for clinical assessment of early-stage breast cancer

Johan Staaf, Jari Häkkinen, Cecilia Hegardt et al. · npj Breast Cancer · 2022 · 91 citations · Full text

Breast Oncology, Prognosis, Pathology +19

Impact of 27-hydroxylase (CYP27A1) and 27-hydroxycholesterol in breast cancer

Siker Kimbung, Ching‐yi Chang, Pär‐Ola Bendahl et al. · Endocrine Related Cancer · 2017 · 90 citations · Full text

High expression of cholesterol biosynthesis genes is associated with resistance to statin treatment and inferior survival in breast cancer

Siker Kimbung, Barbara Lettiero, Maria Feldt et al. · Oncotarget · 2016 · 85 citations · Full text

Cholesterol Biosynthesis Genes, Cholesterol Biosynthesis, Radiation Oncology +13

Statin-induced anti-proliferative effects via cyclin D1 and p27 in a window-of-opportunity breast cancer trial

Maria Feldt, Olöf Bjarnadottir, Siker Kimbung et al. · Journal of Translational Medicine · 2015 · 81 citations · Full text

Tumor Biology, Statin-induced Anti-proliferative Effects, Breast Oncology +11